Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
Attovia Therapeutics successfully debuted on the Nasdaq under ticker ATTO, pricing its initial public offering at $17.00 per share. The stock opened at $21.00, giving the clinical-stage biopharmaceutical company an approximate market capitalization of $904 million.
Key figures
- Offering Price
- $17.00
- Market cap
- $904 million
- Open price
- $21.00
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.